Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
Authors
Keywords
-
Journal
Trials
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1186/s13063-019-3689-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
- (2018) Richard I. G. Holt et al. BRITISH JOURNAL OF PSYCHIATRY
- Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis
- (2017) John A. Naslund et al. GENERAL HOSPITAL PSYCHIATRY
- Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder
- (2017) Julie R. Larsen et al. JAMA Psychiatry
- Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial
- (2016) Pelle L. Ishøy et al. DIABETES OBESITY & METABOLISM
- The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
- (2016) Helene Speyer et al. World Psychiatry
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
- (2015) Amy L Whitehead et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation: Systematic review
- (2013) K. Barnard et al. DIABETES CARE
- Incidence of Cardiovascular Outcomes and Diabetes Mellitus Among Users of Second-Generation Antipsychotics
- (2013) Leslie Citrome et al. JOURNAL OF CLINICAL PSYCHIATRY
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- Twenty-five year mortality of a community cohort with schizophrenia
- (2010) Steve Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- Obesity, serious mental illness and antipsychotic drugs
- (2009) Richard I. G. Holt et al. DIABETES OBESITY & METABOLISM
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started